Nanocarriers: a tool to overcome biological barriers in siRNA delivery

Bibliography

• Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol 2003;11:457-67
   Google Scholar
• Huang C, Li M, Chen C, Yao Q. Small interfering RNA therapy in cancer: mechanism, potential targets, and clinical applications. Expert Opin Ther Targets 2008;12:637-45
   PubMed Web of Science ®Google Scholar
• Cheng K, Mahato RI. siRNA delivery and targeting. Mol Pharm 2009;6:649-50
   PubMedGoogle Scholar
• Jeong JH, Kim SW, Park TG. Molecular design of functional polymers for gene therapy. Prog Polym Sci 2007;32:1239-74
   Web of Science ®Google Scholar
• Behlke MA. Progress towards in vivo use of siRNAs. Mol Ther 2006;13:644-70
   PubMed Web of Science ®Google Scholar
• Wang XL, Xu R, Wu X, Targeted systemic delivery of a therapeutic siRNA with a multifunctional carrier controls tumor proliferation in mice. Mol Pharm 2009;6:738-46
   PubMed Web of Science ®Google Scholar
• Aagaard L, Rossi JJ. RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 2007;59:75-86
   PubMed Web of Science ®Google Scholar
• Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003;422:37-44
   PubMed Web of Science ®Google Scholar
• Panyam J, Zhou WZ, Prabha S, Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene delivery. Faseb J 2002;16:1217-26
   PubMed Web of Science ®Google Scholar
• Vasir JK, Reddy MK, Labhasetwar VD. Nanosystems in drug targeting: opportunities and challenges. Current Nanoscience 2005;1:47-64
   Web of Science ®Google Scholar
• Chakraborty C. Potentiality of small interfering RNAs (siRNA) as recent therapeutic targets for gene-silencing. Curr Drug Targets 2007;8:469-82
   PubMed Web of Science ®Google Scholar
• Wilson JA, Richardson CD. Future promise of siRNA and other nucleic acid based therapeutics for the treatment of chronic HCV. Infect Disord Drug Targets 2006;6:43-56
   PubMedGoogle Scholar
• Storvold GL, Andersen TI, Perou CM, siRNA: a potential tool for future breast cancer therapy? Crit Rev Oncog 2006;12:127-50
   PubMedGoogle Scholar
• Khaled A, Guo S, Li F, Guo P. Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano Lett 2005;5:1797-08
   PubMed Web of Science ®Google Scholar
• Blackburn WH, Dickerson EB, Smith MH, Peptide-functionalized nanogels for targeted siRNA delivery. Bioconjug Chem 2009;20:960-8
   PubMed Web of Science ®Google Scholar
• Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 2006;5:1909-17
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Taira K. Ligand-targeted delivery of therapeutic siRNA. Pharm Res 2006;23:1631-40
   PubMed Web of Science ®Google Scholar
• Davis ME. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 2009;6:659-68
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhao B, Jiang H, Cationic lipids and polymers mediated vectors for delivery of siRNA. J Control Release 2007;123:1-10
   PubMed Web of Science ®Google Scholar
• Neu M, Fischer D, Kissel T. Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 2005;7:992-1009
   PubMed Web of Science ®Google Scholar
• Gao K, Huang L. Nonviral methods for siRNA delivery. Mol Pharm 2009;6:651-8
   PubMed Web of Science ®Google Scholar
• Gary DJ, Puri N, Won YY. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 2007;121:64-73
   PubMed Web of Science ®Google Scholar
• Dash PR, Read ML, Barrett LB, Factors affecting blood clearance and in vivo distribution of polyelectrolyte complexes for gene delivery. Gene Ther 1999;6:643-50
   PubMed Web of Science ®Google Scholar
• Davis ME, Zuckerman JE, Choi CHJ, Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010;464:1067-70
   PubMed Web of Science ®Google Scholar
• Vornlocher H-P. Antibody-directed cell-type-specific delivery of siRNA. Trends Mol Med 2006;12:1-3
   PubMed Web of Science ®Google Scholar
• Elbakry A, Zaky A, Liebl R, Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett 2009;9:2059-64
   PubMed Web of Science ®Google Scholar
• Juliano R, Bauman J, Kang H, Ming X. Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol Pharm 2009;6:686-95
   PubMed Web of Science ®Google Scholar
• Kim SH, Jeong JH, Lee SH, Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release 2008;129:107-16
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces 2010;75:1-18
   PubMed Web of Science ®Google Scholar
• Baigude H, Rana TM. Delivery of therapeutic RNAi by nanovehicles. Chembiochem 2009;10:2449-54
   PubMed Web of Science ®Google Scholar
• Yezhelyev MV, Qi L, O'Regan RM, Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. J Am Chem Soc 2008;130:9006-12
   PubMed Web of Science ®Google Scholar
• Buyens K, Demeester J, De Smedt SS, Sanders NN. Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes. Langmuir 2009;25:4886-91
   PubMed Web of Science ®Google Scholar
• Jeong JH, Mok H, Oh YK, Park TG. siRNA conjugate delivery systems. Bioconjug Chem 2009;20:5-14
   PubMed Web of Science ®Google Scholar
• Kam NW, Liu Z, Dai H. Functionalization of carbon nanotubes via cleavable disulfide bonds for efficient intracellular delivery of siRNA and potent gene silencing. J Am Chem Soc 2005;127:12492-3
   PubMed Web of Science ®Google Scholar
• Derfus AM, Chen AA, Min DH, Targeted quantum dot conjugates for siRNA delivery. Bioconjug Chem 2007;18:1391-6
   PubMed Web of Science ®Google Scholar
• Hermanson GT. Heterobifunctional crosslinkers. In: Bioconjugate techniques, Illinois, USA: Elsevier; 2008
   Google Scholar
• Giljohann DA, Seferos DS, Prigodich AE, Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 2009;131:2072-3
   PubMed Web of Science ®Google Scholar
• Medarova Z, Pham W, Farrar C, In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007;13:372-7
   PubMed Web of Science ®Google Scholar
• Xia CF, Zhang Y, Zhang Y, Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology. Pharm Res 2007;24:2309-16
   PubMed Web of Science ®Google Scholar
• Wu D, Pardridge WM. Central nervous system pharmacologic effect in conscious rats after intravenous injection of a biotinylated vasoactive intestinal peptide analog coupled to a blood-brain barrier drug delivery system. J Pharmacol Exp Ther 1996;279:77-83
   PubMed Web of Science ®Google Scholar
• Akhtar S, Benter IF. Nonviral delivery of synthetic siRNAs in vivo. J Clin Invest 2007;117:3623-32
   PubMed Web of Science ®Google Scholar
• Kim SH, Jeong JH, Lee SH, LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI. Bioconjug Chem 2008;19:2156-62
   PubMed Web of Science ®Google Scholar
• Daniel MC, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev 2004;104:293-346
   PubMed Web of Science ®Google Scholar
• Shukla R, Bansal V, Chaudhary M, Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005;21:10644-54
   PubMed Web of Science ®Google Scholar
• Lee JS, Green JJ, Love KT, Gold, poly(beta-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 2009;9:2402-6
   PubMed Web of Science ®Google Scholar
• Kim HR, Kim IK, Bae KH, Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA. Mol Pharm 2008;5(4):622-31
   PubMed Web of Science ®Google Scholar
• Bouclier C, Moine L, Hillaireau H, Physicochemical characteristics and preliminary in vivo biological evaluation of nanocapsules loaded with siRNA targeting estrogen receptor alpha. Biomacromolecules 2008;9:2881-90
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Surface-modified LPD nanoparticles for tumor targeting. Ann N Y Acad Sci 2006;1082:1-8
   PubMed Web of Science ®Google Scholar
• Xu Y, Szoka FC Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996;35:5616-23
   PubMed Web of Science ®Google Scholar
• Li SD, Huang L. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Mol Pharm 2006;3:579-88
   PubMed Web of Science ®Google Scholar
• Akerman ME, Chan WC, Laakkonen P, Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 2002;99:12617-21
   PubMed Web of Science ®Google Scholar
• Gao X, Cui Y, Levenson RM, In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004;22:969-76
   PubMed Web of Science ®Google Scholar
• Derfus AM, Chan WCW, Bhatia SN. Intracellular delivery of quantumdots for live cell labeling and organelle tracking. Adv Mater 2004;16:961-6
   Web of Science ®Google Scholar
• Boussif O, Lezoualc'h F, Zanta MA, A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995;92:7297-301
   PubMed Web of Science ®Google Scholar
• Sonawane ND, Szoka FC Jr, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003;278:44826-31
   PubMed Web of Science ®Google Scholar
• Bianco A, Kostarelos K, Prato M. Opportunities and challenges of carbon-based nanomaterials for cancer therapy. Expert Opin Drug Deliv 2008;5:331-42
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2007;2:751-60
   PubMed Web of Science ®Google Scholar
• McCarroll J, Baigude H, Yang CS, Rana TM. Nanotubes functionalized with lipids and natural amino acid dendrimers: a new strategy to create nanomaterials for delivering systemic RNAi. Bioconjug Chem 2009;21:56-63
   Web of Science ®Google Scholar
• Herrero MA, Toma FM, Al-Jamal KT, Synthesis and characterization of a carbon nanotube-dendron series for efficient siRNA delivery. J Am Chem Soc 2009;131:9843-8
   PubMed Web of Science ®Google Scholar
• Liu Z, Winters M, Holodniy M, Dai H. siRNA delivery into human T cells and primary cells with carbon-nanotube transporters. Angew Chem Int Ed Engl 2007;46:2023-7
   PubMed Web of Science ®Google Scholar
• Liu Z, Tabakman S, Welsher K, Dai H. Carbon Nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery. Nano Res 2009;2:85-120
   PubMed Web of Science ®Google Scholar
• Stanton MG, Colletti SL. Medicinal chemistry of siRNA delivery. J Med Chem 2010;53:7887-901
   PubMed Web of Science ®Google Scholar
• Mendonca LS, Firmino F, Moreira JN, Transferrin receptor-targeted liposomes encapsulating anti-BCR-ABL siRNA or asODN for chronic myeloid leukemia treatment. Bioconjug Chem 2010;21:157-68
   PubMed Web of Science ®Google Scholar
• Gillies ER, Frechet JM. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 2005;10:35-43
   PubMed Web of Science ®Google Scholar
• Patil ML, Zhang M, Betigeri S, Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjug Chem 2008;19:1396-03
   PubMed Web of Science ®Google Scholar
• Agrawal A, Min DH, Singh N, Functional delivery of siRNA in mice using dendriworms. ACS Nano 2009;3:2495-504
   PubMed Web of Science ®Google Scholar
• Saad M, Garbuzenko OB, Minko T. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. Nanomedicine 2008;3:761-76
   PubMed Web of Science ®Google Scholar
• Chen Y, Bathula SR, Li J, Huang L. Multi-functional nanoparticles delivering siRNA and doxorubicin overcome drug resistance in cancer. J Biol Chem 2010;285:22639-50
   PubMed Web of Science ®Google Scholar
• Taratula1 O, Garbuzenko O, Savla R, Multifunctional nanomedicine platform for cancer specific delivery of siRNA by superparamagnetic iron oxide nanoparticles-dendrimer complexes. Curr Drug Delivery 2011;8:59-69
   PubMed Web of Science ®Google Scholar
• Benoit DSW, Henry SM, Shubin AD, pH-Responsive polymeric siRNA carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of Polo-like Kinase 1. Mol Pharm 2010;7:442-55
   PubMed Web of Science ®Google Scholar
• Huang HY, Kuo WT, Huang YY. Combining gene and chemo therapy using multifunctional polymeric micelles. World Acad Sci Eng Technol 2010;65:1142-5
   Google Scholar
• Convertine AJ, Diab C, Prieve M, pH-Responsive polymeric micelle carriers for siRNA drugs. Biomacromolecules 2010;11:2904-11
   PubMed Web of Science ®Google Scholar
• Musacchio T, Vaze O, D'Souza G, Torchilin VP. Effective Stabilization and delivery of siRNA: reversible siRNA-phospholipid conjugate in nanosized mixed polymeric micelles. Bioconjugate Chem 2010;21:1530-6
   PubMed Web of Science ®Google Scholar
• Fattal E, Barratt G. Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. Br J Pharmacol 2009;157:179-94
   PubMed Web of Science ®Google Scholar
• Tokatlian T, Segura T. siRNA applications in nanomedicine. Nanomed Nanobiotechnol 2010;2:305-15
   Web of Science ®Google Scholar
• Bartlett DW, Davis ME. Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles. Biotechnol Bioeng 2008;99:975-85
   PubMed Web of Science ®Google Scholar
• Xia T, Kovochich M, Liong M, Polyethyleneimine coating enhances the cellular uptake of mesoporous silica nanoparticles and allows safe delivery of siRNA and DNA constructs. ACS Nano 2009;3:3273-86
   Google Scholar